DRIVE: Diabetes reversing implants with enhanced viability and long-term efficacy (645991-2).
- Researcher(s):
- For CIBER BBN Principal Investigator
- Period:
- from 2015 to 2019
- Financing entity:
- COMUNIDAD EUROPEA H2020- NMP-10-2014: Biomaterials for the treatment of Diabetes Mellitus.